Alcon AG
SIX:ALC

Watchlist Manager
Alcon AG Logo
Alcon AG
SIX:ALC
Watchlist
Price: 65.4 CHF 3.09% Market Closed
Market Cap: 32.7B CHF

Alcon AG
Common Shares Outstanding

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Alcon AG
Common Shares Outstanding Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
Alcon AG
SIX:ALC
Common Shares Outstanding
$494.6m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Coltene Holding AG
SIX:CLTN
Common Shares Outstanding
CHf6m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Medartis Holding AG
SIX:MED
Common Shares Outstanding
CHf12.4m
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Ypsomed Holding AG
SIX:YPSN
Common Shares Outstanding
CHf13.6m
CAGR 3-Years
0%
CAGR 5-Years
2%
CAGR 10-Years
1%
IVF Hartmann Holding AG
SIX:VBSN
Common Shares Outstanding
CHf2.4m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
No Stocks Found

Alcon AG
Glance View

Alcon AG, headquartered in Geneva, Switzerland, emerges as a global leader in eye care, having spun off from Novartis in 2019 to operate independently. The company traces its roots back to a small pharmacy established in Fort Worth, Texas, in 1945, gradually expanding under the strategic vision of its founders. Today, Alcon stands at the intersection of innovation and necessity, catering to a world increasingly aware of eye health. The firm specializes in two main sectors: Surgical and Vision Care. In the Surgical division, Alcon offers advanced technologies and devices for ophthalmic surgery, encompassing cataract, retinal, and refractive procedures. Through these innovations, Alcon not only enhances patient outcomes but also streamlines operations for eye care professionals, carving out a significant market share in surgical solutions. Meanwhile, the Vision Care segment thrives by addressing the burgeoning demand for contact lenses and ocular health products. Alcon’s portfolio features daily disposable and reusable lenses, supported by innovative technologies that prioritize comfort and clarity of vision. Additionally, the company provides comprehensive eye care products, including lens care solutions, which enhance user satisfaction and ensure sustained demand. Alcon’s revenue model hinges on its ability to deliver cutting-edge products that meet the evolving needs of consumers and professionals alike. Through strategic investments in research and development and a strong distribution network, Alcon perpetually reinforces its market presence, securing its position as a formidable player in the eye care industry.

ALC Intrinsic Value
67.41 CHF
Undervaluation 3%
Intrinsic Value
Price

See Also

What is Alcon AG's Common Shares Outstanding?
Common Shares Outstanding
494.6m USD

Based on the financial report for Sep 30, 2025, Alcon AG's Common Shares Outstanding amounts to 494.6m USD.

What is Alcon AG's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
0%

Over the last year, the Common Shares Outstanding growth was 0%.

Back to Top